Top Story
Social Media: Pharma’s Prescription for Return on Investment
In an industry that prides itself on preciseness, taking a deep dive into metrics, measurements, and insights can help drive and prove the value of your social media programs. Peter Friedman discusses five ways brand teams can find value in social media.
...Read more |
| |
|
| |
Product Positioning
Bigger Than Brand: Portfolio Positioning for Pharma
For years, pharma has reduced the impact of loss of exclusivity by launching alternative molecules to treat the same condition. While the commercial intention of this is to maximize the value gained from a therapy area, the execution of a portfolio strategy can impact this if done poorly. With pharma in the midst of a patent cliff, portfolios of treatments are becoming more common, and the need for a clear co-positioning strategy has never been greater, writes Jenna Earl.
...Read more |
Redefining what marketing means to pharma. Creating engagements with value and purpose. Realize your potential with integrated services from Intouch Solutions.
 Intouchsol.com/Genome
|
Personalized Medicine
Syncing Personalized Medicine and Marketing
The new generation of individualized treatments will require life sciences companies to evolve how they reach and educate the healthcare community. Matt Wallach asks, are your commercial operations up to the task?
...Read more |
Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What’s Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
 Contact your sales rep for more information and to secure your sponsorship. |
Technology
Time for a Wearable Strategy
Analysts are saying that more than 4 million Apple Watches were sold in the Q2 2015, grabbing up to 75 percent of the smartwatch market, way ahead of nearest rival Samsung with about 7.5 percent of the market. This is proof, writes Peter Houston, of the unstoppable rise of wearable technology, thanks in particular to health and fitness applications.
...Read more |
Pharmaceutical Executive E-Book – Coming October 2015: Changing Contours of Commercialization: Impact of US Health Reform on Patients, Payers and Providers
Key Topics include:
- Phase-in of the 2010 Affordable Care Act: Five stages of pain and plenty
- Pay for Performance and Shared Savings Programs – Implications for Pharma Marketers
- How ACO models are driving physician and provider decision-making
- Primer on policies and financial drivers impacting payer markets – MLR, MSSP, CMS etc.
 Contact your sales rep for more information and to secure your sponsorship. |
Comment
Turing Pharmaceuticals: The Pre-Gouging Price
Casey McDonald offers a slightly different take on the controversial Turing Pharmaceuticals/Martin Shkreli business.
...Read more |
|
 |
 //Exelixis (South San Francisco, CA) announced three appointments as the company prepares for the potential commercialization of its lead compound, cabozantinib. William Berg, M.D. joined the company as Senior Vice President of Medical Affairs, Jonathan Berndt as Vice President of Sales, and Gregg Bernier as Vice President of Marketing.//Rosa Griffin joined Intronix Technologies Corporation (Toronto, Ontario) as Sales and Marketing Manager.//iCAD (Nashua, NH) appointed Rodney Hawkins as Vice President of Marketing and Kathleen Kelly as Vice President of Sales for the company’s Cancer Detection business.// |
|
 |
December 2–3: Publication Planning
Philadelphia, PA
January 28–29, 2016: 11th Summit on Biosimilars
Alexandria, VA
February 23–24, 2016: Oncology Commercialization and Market Access
San Francisco, CA.
|
